2,904
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Engineering of a novel optimized platform for sublingual delivery with novel characterization tools: in vitro evaluation and in vivo pharmacokinetics study in human

, , & ORCID Icon
Pages 918-931 | Received 24 Apr 2017, Accepted 22 May 2017, Published online: 09 Jun 2017

References

  • Ali AA, Sayed OM. (2013). Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins. Pharm Dev Technol 18:1042–50.
  • Anderson MJ, Whitcomb PJ. (2016). DOE simplified: practical tools for effective experimentation. New York: Productivity Press.
  • Antony J. (2014). Design of experiments for engineers and scientists. Oxford: Elsevier.
  • Badawy MA, Kamel AO, Sammour OA. (2016). Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study. Drug Deliv 23:818–27.
  • Bayrak Z, Tas C, Tasdemir U, et al. (2011). Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation. Eur J Pharm Biopharm 78:499–505.
  • Beckett AH, Moffat AC. (1969). Correlation of partition coefficients in n-heptane-aqueous systems with buccal absorption data for a series of amines and acids. J Pharm Pharmacol 21:144S.
  • Berger MP, Wong W-K. (2009). An introduction to optimal designs for social and biomedical research. Chichester, UK: John Wiley & Sons.
  • Bertram U, Bodmeier R. (2006). In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci 27:62–71.
  • Bhardwaj TR, Kanwar M, Lal R, Gupta A. (2000). Natural gums and modified natural gums as sustained-release carriers. Drug Dev Ind Pharm 26:1025–38.
  • Bi Y, Sunada H, Yonezawa Y, Danjo K. (1999). Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm 25:571–81.
  • Cabezas DM, Diehl BWK, Tomás MC. (2016). Emulsifying properties of hydrolysed and low HLB sunflower lecithin mixtures. Eur J Lipid Sci Technol 118:975–83.
  • Cai X, Luan Y, Jiang Y, et al. (2012). Huperzine A–phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharm 433:102–11.
  • Cheng L, Xu P-H, Shen B-D, et al. (2015). Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride. Int J Pharm 489:148–57.
  • Chow T. (2003). Size-dependent adhesion of nanoparticles on rough substrates. J Phys Condens Matter 15:L83.
  • Cui F, Shi K, Zhang L, et al. (2006). Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release 114:242–50.
  • Curran M, Robinson D. (2008). Mosapride in gastrointestinal disorders. Drugs 68:981–91.
  • De Almeida PDV, Gregio A, Machado M, et al. (2008). Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 9:72–80.
  • De Boer AG, De Leede LG, Breimer DD. (1984). Drug absorption by sublingual and rectal routes. Br J Anaesth 56:69–82.
  • ElMeshad AN, El Hagrasy AS. (2011). Characterization and optimization of orodispersible mosapride film formulations. AAPS PharmSciTech 12:1384–92.
  • Fujita T. (1982). Structural investigation of the divalent iron and manganese complexes with citric acid by infrared spectroscopy. Chem Pharm Bull 30:3461–5.
  • Guo B, Liu H, Li Y, et al. (2014). Application of phospholipid complex technique to improve the dissolution and pharmacokinetic of probucol by solvent-evaporation and co-grinding methods. Int J Pharm 474:50–6.
  • Guo J-H, Skinner G, Harcum W, Barnum P. (1998). Pharmaceutical applications of naturally occurring water-soluble polymers. Pharm Sci Technol Today 1:254–61.
  • Gupta RB, Kompella UB. (2006). Nanoparticle technology for drug delivery. New York: Taylor & Francis.
  • Hammond EG, Johnson LA, Su C, et al. (2005). Soybean oil. Bailey's industrial oil and fat products. Chichester, UK: John Wiley & Sons, Inc.
  • Harris D, Robinson JR. (1992). Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 81:1–10.
  • Hassan EE, Gallo JM. (1990). A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 7:491–5.
  • Hearnden V, Sankar V, Hull K, et al. (2012). New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 64:16–28.
  • Hills B. (1996). Gastric surfactant and the hydrophobic mucosal barrier. Gut 39:621–4.
  • Jena SK, Singh C, Dora CP, Suresh S. (2014). Development of tamoxifen–phospholipid complex: novel approach for improving solubility and bioavailability. Int J Pharm 473:1–9.
  • Jiang Q, Yang X, Du P, et al. (2016). Dual strategies to improve oral bioavailability of oleanolic acid: Enhancing water-solubility, permeability and inhibiting cytochrome P450 isozymes. Eur J Pharm Biopharm 99:65–72.
  • Kassem AA, Abd El-Alim SH, Basha M, Salama A. (2017). Phospholipid complex enriched micelles: a novel drug delivery approach for promoting the antidiabetic effect of repaglinide. Eur J Pharm Sci 99:75–84.
  • Khan K, Rhodes C. (1975). Water-sorption properties of tablet disintegrants. J Pharm Sci 64:447–51.
  • Khurana RK, Bansal AK, Beg S, et al. (2017). Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: systematic development, characterization and evaluation. Int J Pharm 518:289–306.
  • Kim HJ, Lee SH, Lim EA, Kim J-S. (2011). Formulation optimization of solid dispersion of mosapride hydrochloride. Arch Pharm Res 34:1467–75.
  • Kolah AK, Asthana NS, Vu DT, et al. (2006). Reaction kinetics of the catalytic esterification of citric acid with ethanol. Ind Eng Chem Res 46:3180–7.
  • Lamprecht A, Schäfer U, Lehr C-M. (2001). Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 18:788–93.
  • Larkin P. (2011). Infrared and Raman spectroscopy; principles and spectral interpretation. Oxford: Elsevier.
  • Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. (1991). The handbook of infrared and Raman characteristic frequencies of organic molecules. Oxford: Elsevier.
  • Maiti K, Mukherjee K, Gantait A, et al. (2007). Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155–63.
  • Mathiowitz E, Chickering III DE, Lehr C-M. (2013). Bioadhesive drug delivery systems: fundamentals, novel approaches, and development. New York: CRC Press.
  • Montgomery DC. (2008). Design and analysis of experiments. Chichester, UK: John Wiley & Sons.
  • Nakamura F, Ohta R, Machida Y, Nagai T. (1996). In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm 134: 173–81.
  • Park JH, Robinson JR. (2008). Effect of a hydrophobic phospholipid lining of the gastric mucosa in bioadhesion. Pharm Res 25:16–24.
  • Patel VF, Liu F, Brown MB. (2011). Advances in oral transmucosal drug delivery. J Control Release 153:106–16.
  • Patil SS, Dhabale PN, Kuchekar BS. (2009). Development and statistical validation of spectrophotometric method for the estimation of mosapride in pharmaceutical formulation. Int J PharmTech Res 1:1458–61.
  • Rachid O, Rawas-Qalaji M, Simons FER, Simons KJ. (2011). Dissolution testing of sublingual tablets: a novel in vitro method. AAPS PharmSciTech 12:544–52.
  • Rathbone MJ, Hadgraft J. (1991). Absorption of drugs from the human oral cavity. Int J Pharm 74:9–24.
  • Rowe RC, Sheskey PJ, Owen SC, et al. (2006). Handbook of pharmaceutical excipients. Pharmaceutical Press.
  • Ruth M, Finizia C, Cange L, Lundell L. (2003). The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 15:1115–21.
  • Ruth M, Hamelin B, Rohss K, Lundell L. (1998). The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 12:35–40.
  • Sakashita M, Yamaguchi T, Miyazaki H, et al. (1993). Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Arzneimittelforschung 43:867–72.
  • Schäfer-Korting M. (2010). Drug delivery. Berlin: Springer.
  • Schiermeier S, Schmidt PC. (2002). Fast dispersible ibuprofen tablets. Eur J Pharm Sci 15:295–305.
  • Semalty A, Semalty M, Rawat BS, et al. (2009). Pharmacosomes: the lipid-based new drug delivery system. Expert Opin Drug Deliv 6:599–612.
  • Singh C, Bhatt TD, Gill MS, Suresh S. (2014). Novel rifampicin–phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation. Int J Pharm 460:220–7.
  • Smart JD. (2005). The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 57:1556–68.
  • Smith WF. (2005). Experimental design for formulation. New York: ASA-SIAM Series on Statistics and Applied Probability.
  • Stockwell A, Davis S, Walker S. (1986). In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J Control Release 3:167–75.
  • Teo YY, Misran M, Low KH, Zain SM. (2011). Effect of unsaturation on the stability of C-18 polyunsaturated fatty acids vesicles suspension in aqueous solution. Bull Korean Chem Soc 32:59–64.
  • Tønnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm 28:621–30.
  • Ushikubo FY, Cunha RL. (2014). Stability mechanisms of liquid water-in-oil emulsions. Food Hydrocoll 34:145–53.
  • Van Nieuwenhuyzen W. (1981). The industrial uses of special lecithins: a review. J Am Oil Chem Soc 58:886–8.
  • Yanyu X, Yunmei S, Zhipeng C, Qineng P. (2006). The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 307:77–82.
  • Yue P-F, Yuan H-L, Li X-Y, et al. (2010). Process optimization, characterization and evaluation in vivo of oxymatrine–phospholipid complex. Int J Pharm 387:139–46.
  • Yue P-F, Zheng Q, Liao M-X, et al. (2010). Process optimization, characterization, and release study in vitro of an intravenous puerarin lipid micropheres loaded with the phospholipid complex. J Dispers Sci Technol 32:1–10.